Trial intelligence / Profile preview

Imatinib Re-Challenge in Advanced GIST (RIGHT)

NCT01151852Phase 3Completed

Sponsor
Asan Medical Center
Start
Jun 2010
Primary completion
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by Asan Medical Center. Started Jun 2010; status: completed.

02

Drugs

03

Conditions

gastrointestinal stromal tumor (GIST)

Beyond the preview

Go deeper on NCT01151852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01151852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call